This invention pertains to inhibitors of atrial natriuretic peptide receptor A (NPRA) function, such as small interfering RNA (siRNA), useful for reducing the inflammation associated with many human diseases, such as asthma, respiratory syncytial virus (RSV) infection, and cancers (such as melanoma, lung cancer, and/or ovarian cancer) by interfering with NPRA gene expression or otherwise reducing NPRA function within a subject; and methods for treating a subject suffering from, or at risk of developing, an inflammatory disease, respiratory allergy (such as allergic rhinitis and asthma), viral infection, and/or cancer by administering such NPRA inhibitors to the subject.
Mohapatra, Shyam S.; Xu, Weidong; Kong, Xiaoyuan; and Wang, Xiaoqin, "Materials and methods for reducing inflammation by inhibition of the atrial natriuretic peptide receptor" (2011). USF Patents. 451.
University of South Florida